Stockholm3 blood test detected 90% of aggressive prostate cancer cases compared to 74% for PSA tests in a study of over ...

Black men are much more likely to die from prostate cancer than the general population. A group of Chicago-area researchers ...

Black men are much more likely to die from prostate cancer than the general population. A group of Chicago-area researchers ...

Researchers at the University of British Columbia have identified a new form of hereditary prostate cancer that, while rare, ...

A large analysis suggests that a multivariable risk assessment tool, called Stockholm3, can detect substantially more ...

Researchers have uncovered a rare inherited mutation linked to prostate cancer—and it could help identify at-risk families ...

A new study suggests the investigational Stockholm3 blood test may improve the early detection of aggressive prostate cancer ...

New technologies can potentially save lives by helping identify prostate cancer earlier, and transforming the way doctors ...

According to the institute, a single, reliable test to differentiate aggressive, life-threatening cancers from slower-growing ...

NeoGenomics, Inc.(NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the launch of PTEN IHC CDx, the first immunohistochemistry (IHC) ...

The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...

Increasing use of blood tests to detect prostate cancer is leading to overworked doctors. NTNU has now created an AI diagnostic tool that can help lighten the burden. Diagnostic tools based on ...